Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717989 · ClinicalTrials.gov registry record
Study to Evaluate the Prospective Payment System
A clinical trial, sponsored by Amgen.
- Completed
- Registry status
- 2,248
- Enrollment target
NCT01717989 is a clinical trial that has completed, run by Amgen. The registered enrollment target is 2,248 participants.
The verdict
NCT01717989 has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- 2,248 participants
- Enrollment target
Study Summary
To describe trends in treatment patterns of Small Dialysis Organizations (SDOs) prior to and during the implementation of the Centers for Medicare and Medicaid Services' (CMS') policy \[End Stage Renal Disease (ESRD) Prospective Payment System (PPS)\] to bundle reimbursement for all dialysis services. Specifically, to describe CMS ESRD PPS quality performance measures for dialysis centers over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,248 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01717989
The ClinicalTrials.gov registry entry for NCT01717989 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01717989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01717989 about?
NCT01717989 is a clinical study titled "Study to Evaluate the Prospective Payment System". To describe trends in treatment patterns of Small Dialysis Organizations (SDOs) prior to and during the implementation of the Centers for Medicare and Medicaid Services' (CMS') policy \[End Stage Renal Disease (ESRD) Prospective Payment System (PPS)\] to bundle reimbursement for all dialysis service...
What is the current status of trial NCT01717989?
This trial is currently completed. The enrollment target is 2,248 participants. The study started on 2010-06. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01717989?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.